Advanced dPCR (Digital PCR) technology provides higher accuracy and reproducibility than traditional PCR technology in the amplification and analysis of nucleic acids. The dPCR technology is an innovative PCR that allows amplification and directs quantification of nucleic acids such as DNA, RNA, cDNA, and methylated DNA with high precision. The dPCR technology is not dependent on the number of amplification cycles to quantify the initial sample amount and provides absolute quantification of nucleic acids. dPCR can analyze a small amount of sample and provide higher accuracy, precision, and efficiency than the conventional PCR technology.
Analysts forecast the Global Digital PCR market to grow at a CAGR of 26.45 percent over the period 2014-2019.
The report covers the present scenario and the growth prospects of the Global dPCR market for the period 2015-2019. To calculate the market size, the report considers the revenue generated from the sales of dPCR products: dPCR consumables, and dPCR instruments.
The dPCR technologies have a broad range of applications in various fields including:
- Drug discovery and development
- Clinical diagnostics
Global dPCR Market 2015-2019, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the Americas, the APAC region, and the EMEA region; it also covers the market landscape and its growth prospects in the coming years. The report also includes a discussion of the key vendors operating in this market.
- Bio-Rad Laboratories
- RainDance Technologies
- Thermo Fisher Scientific
Other Prominent Vendors
- Abbott Laboratories
- Analytik Jena
- Becton Dickinson
- Bibby Scientific
- Biosearch Technologies
- BIOTECON Diagnostics
- Integrated DNA Technologies
- Stilla Technologies
- Advances in Technology
- Availability of Alternate Technologies
- Adoption of dPCR
Key Questions Answered in this Report
- What will the market size be in 2019 and what will the growth rate be?
- What are the key market trends?
- What is driving this market?
- What are the challenges to market growth?
- Who are the key vendors in this market space?
- What are the market opportunities and threats faced by the key vendors?
Have any Query on the Report get your Queries Resolved at http://www.sandlerresearch.org/inquire-before-buying?rname=31069 .
(Prices start at US $2500 for a single user PDF)
Biomarkers are molecules present in the blood, other body fluids such as serum, urine, or in tissue that are indicators of a disease or abnormal conditions. Biomarkers are mostly used as diagnostic tools. Biomarkers help in identifying potential drug failures in initial stages, leading to savings in time and costs. Biomarkers are becoming an essential part of the drug discovery process.
qPCR (Real-time Polymerase Chain Reaction) and dPCR (Digital Polymerase Chain Reaction) are the advanced PCR technologies that provide higher accuracy and reproducibility in nucleic acids amplification and analysis. qPCR allows amplification and quantification of a targeted DNA molecule in real-time. While dPCR is an advanced PCR that allows direct quantification and amplification of nucleic acids including RNA, DNA, cDNA, methylated DNA. It does not rely on the number of amplification cycles to measure the initial sample amount and provides absolute quantification of nucleic acid.